AU6194100A - An oral composition having as a first active ingredient budesonide and as a second active ingredient an antibiotic, for use in intestinal conditions, especiallycrohn's disease - Google Patents
An oral composition having as a first active ingredient budesonide and as a second active ingredient an antibiotic, for use in intestinal conditions, especiallycrohn's diseaseInfo
- Publication number
- AU6194100A AU6194100A AU61941/00A AU6194100A AU6194100A AU 6194100 A AU6194100 A AU 6194100A AU 61941/00 A AU61941/00 A AU 61941/00A AU 6194100 A AU6194100 A AU 6194100A AU 6194100 A AU6194100 A AU 6194100A
- Authority
- AU
- Australia
- Prior art keywords
- active ingredient
- especiallycrohn
- antibiotic
- disease
- oral composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000004480 active ingredient Substances 0.000 title 2
- VOVIALXJUBGFJZ-KWVAZRHASA-N Budesonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O VOVIALXJUBGFJZ-KWVAZRHASA-N 0.000 title 1
- 239000003242 anti bacterial agent Substances 0.000 title 1
- 230000003115 biocidal effect Effects 0.000 title 1
- 229960004436 budesonide Drugs 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 230000000968 intestinal effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9902673A SE9902673D0 (en) | 1999-07-12 | 1999-07-12 | New composition |
| SE9902673 | 1999-07-12 | ||
| PCT/SE2000/001467 WO2001003701A1 (en) | 1999-07-12 | 2000-07-07 | An oral composition having as a first active ingredient budesonide and as a second active ingredient an antibiotic, for use in intestinal conditions, especially crohn's disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU6194100A true AU6194100A (en) | 2001-01-30 |
Family
ID=20416477
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU61941/00A Abandoned AU6194100A (en) | 1999-07-12 | 2000-07-07 | An oral composition having as a first active ingredient budesonide and as a second active ingredient an antibiotic, for use in intestinal conditions, especiallycrohn's disease |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU6194100A (en) |
| SE (1) | SE9902673D0 (en) |
| WO (1) | WO2001003701A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7568309B2 (en) | 2004-06-30 | 2009-08-04 | Weyerhaeuser Nr Company | Method and system for producing manufactured seeds |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE8903914D0 (en) * | 1989-11-22 | 1989-11-22 | Draco Ab | ORAL COMPOSITION FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASES |
-
1999
- 1999-07-12 SE SE9902673A patent/SE9902673D0/en unknown
-
2000
- 2000-07-07 WO PCT/SE2000/001467 patent/WO2001003701A1/en not_active Ceased
- 2000-07-07 AU AU61941/00A patent/AU6194100A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001003701A1 (en) | 2001-01-18 |
| SE9902673D0 (en) | 1999-07-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU7429100A (en) | Chondrocyte compositions, preparation and use thereof | |
| HUP0203312A3 (en) | Pharmaceutically active sulfonamide derivatives, process for their preparation, and pharmaceutical compositions and their use | |
| HUP0103341A3 (en) | Azetidine derivatives, preparation and pharmaceutical compositions thereof | |
| AU2002239282A1 (en) | Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof | |
| AU3076700A (en) | 2h-phthalazin-1-one derivatives and drugs comprising these derivatives as the active ingredient | |
| AU3192700A (en) | Medicinal compositions | |
| AU4024100A (en) | Anti-caries oral care compositions | |
| AU5326100A (en) | Pharmaceutical compositions and methods for use | |
| ZA200308221B (en) | Pharmaceutical compositions for oral and topical administration. | |
| AU4328800A (en) | Pharmaceutical formulation | |
| AU2005300A (en) | Medicinal compositions | |
| AU1887401A (en) | Medicinal composition | |
| AU5838398A (en) | Rapamycin formulations for oral administration | |
| AU2564399A (en) | Isoflavanoid formulations for oral administration | |
| AU5965399A (en) | Pharmaceutically active composition | |
| AU1732401A (en) | Medicinal compositions for oral use | |
| AU1053501A (en) | Polyazanaphthalene compound and medicinal use thereof | |
| AU6194100A (en) | An oral composition having as a first active ingredient budesonide and as a second active ingredient an antibiotic, for use in intestinal conditions, especiallycrohn's disease | |
| AU4543500A (en) | Pharmaceutical compositions and uses | |
| AU2870899A (en) | Oral formulation for hydrophilic drugs | |
| AU3839900A (en) | Pharmaceutical formulation | |
| AU6194300A (en) | An oral composition having as a first active ingredient rofleponide and as a second active ingredient an antibiotic, for use in intestinal conditions, especially crohn's disease | |
| AU1556601A (en) | 1,3,4-oxadiazolin-2-one derivatives and drugs containing these derivatives as the active ingredient | |
| AU3845200A (en) | Compound for inhibiting the influx of polymorphonuclear leukocytes (pmns) in a tissue, its selection, pharmaceutical compositions and use | |
| AU6473699A (en) | Aqueous drug formulation for oral application |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |